Literature DB >> 4865295

A double-blind trial of amitriptyline/perphenazine, perphenazine and placebo in chronic withdrawn inert schizophrenics.

A D Collins, J Dundas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4865295     DOI： 10.1192/bjp.113.505.1425

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  5 in total

Review 1.  Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.

Authors:  Marc Krause; Yikang Zhu; Maximilian Huhn; Johannes Schneider-Thoma; Irene Bighelli; Adriani Nikolakopoulou; Stefan Leucht
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-24       Impact factor: 5.270

Review 2.  Perphenazine for schizophrenia.

Authors:  Benno Hartung; Stephanie Sampson; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2015-03-06

Review 3.  Pharmacological treatment of negative symptoms in schizophrenia.

Authors:  Hans-Jürgen Möller; Pal Czobor
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-04-21       Impact factor: 5.270

4.  Use of antidepressants in schizophrenia.

Authors: 
Journal:  Br Med J       Date:  1980-04-12

Review 5.  Randomized Controlled Trials of Add-On Antidepressants in Schizophrenia.

Authors:  Viacheslav Terevnikov; Grigori Joffe; Jan-Henry Stenberg
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.